AMGN
AMGEN INC
Latest Form 4:Sale$825KbyKhosla Rachna (SVP, Business Development) · filed Aug 13, 2026
AMGEN INC (AMGN) has 86 SEC Form 4 filings (125 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 13, 2026.
The most active filer is SVP, Business Development Khosla Rachna with 3 filings. Insiders have net sold $25.7M over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Robert A. Bradway
- Employees:31,500
- HQ:Thousand Oaks, CA, US
- IPO:1983-06-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$29.3M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$233.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Khosla RachnaFirst in 9 months | SVP, Business Development | Sale | 2,000 | $825K | Aug 13 | SEC ↗ |
Khosla RachnaFirst in 9 months | SVP, Business Development | Sale | 1,252 | $521K | Aug 13 | SEC ↗ |
Miller DerekFirst filing | SVP, Human Resources | Sale | 3,890 | $1.6M | Aug 7 | SEC ↗ |
Grygiel Nancy A.First in 3 months | SVP & CCO | Sale | 2,970 | $1.2M | Aug 7 | SEC ↗ |
Grygiel Nancy A.First in 6 months | SVP & CCO | Sale | 1,237 | $400K | May 6 | SEC ↗ |
Santos EstebanFirst filing | EVP, Operations | Sale | 54,792 | $20.8M | Mar 2 | SEC ↗ |
Busch Matthew C.First filing | VP, Finance & CAO | Sale | 1,000 | $376K | Feb 20 | SEC ↗ |
Grygiel Nancy A.First filing | SVP & CCO | Sale | 3,139 | $1.1M | Nov 21 | SEC ↗ |
Khosla RachnaFirst filing | SVP, Business Development | Sale | 890 | $299K | Nov 13 | SEC ↗ |
Gordon MurdoFirst filing | EVP, Global Commercial Ops | Sale | 6,879 | $2.3M | Nov 13 | SEC ↗ |
Congress trading AMGN
See timeline →- RSen. Tommy TubervilleSale$15,001 - $50,0002025-04-15
- DRep. Ro KhannaPurchase$1,001 - $15,0002026-06-02
- RRep. David TaylorPurchase$1,001 - $15,0002026-06-05
- RRep. Maria Elvira SalazarSale$15,001 - $50,0002026-04-17
- DSen. Mark WarnerSale$1,001 - $15,0002026-04-07
- DSen. Mark WarnerSale$1,001 - $15,0002026-04-06
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
AMGEN INC is in the Healthcare sector.